Day-to-day variability in motor threshold during rTMS treatment for depression: Clinical implications
Background: When repetitive transcranial magnetic stimulation (rTMS) is used to treat medication refractory depression, the treatment pulse intensity is individualized according to motor threshold (MT). This measure is often acquired only on the first day of treatment, as per the protocol currently...
Main Authors: | , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-09-01
|
Series: | Brain Stimulation |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1935861X21001509 |
_version_ | 1818736487132299264 |
---|---|
author | Gonçalo Cotovio Albino J. Oliveira-Maia Carter Paul Francisco Faro Viana Daniel Rodrigues da Silva Carolina Seybert Adam P. Stern Alvaro Pascual-Leone Daniel Z. Press |
author_facet | Gonçalo Cotovio Albino J. Oliveira-Maia Carter Paul Francisco Faro Viana Daniel Rodrigues da Silva Carolina Seybert Adam P. Stern Alvaro Pascual-Leone Daniel Z. Press |
author_sort | Gonçalo Cotovio |
collection | DOAJ |
description | Background: When repetitive transcranial magnetic stimulation (rTMS) is used to treat medication refractory depression, the treatment pulse intensity is individualized according to motor threshold (MT). This measure is often acquired only on the first day of treatment, as per the protocol currently approved by Food and Drug Administration. Objective: Here, we aimed to assess daily MT variability across an rTMS treatment course and simulate the effects of different schedules of MT assessment on treatment intensity. Methods: We conducted a naturalistic retrospective study with 374 patients from a therapeutic rTMS program for depression that measures MT daily. Results: For each patient, in almost half the TMS sessions, MT varied on average more than 5% as compared to the baseline MT acquired in the first treatment day. Such variability was only minimally impacted by having different TMS technicians acquiring MT in different days. In a smaller cohort of healthy individuals, we confirmed that the motor hotspot localization method, a critical step for accurate MT assessment, was stable in different days, arguing that daily MT variability reflects physiological variability, rather than an artifact of measurement error. Finally, in simulations of the effect of one-time MT measurement, we found that half of sessions would have been 5% or more above or below target intensity, with almost 5% of sessions 25% above target intensity. The simulated effects of weekly MT measurements were significantly improved. Conclusions: In conclusion, MT varies significantly across days, not fully dependent on methods of MT acquisition. This finding may have important implications for therapeutic rTMS practice regarding safety and suggests that regular MT assessments, daily or at least weekly, would ameliorate the effect. |
first_indexed | 2024-12-18T00:37:56Z |
format | Article |
id | doaj.art-ece9cc47a11a4ce2a05294e0aa57d666 |
institution | Directory Open Access Journal |
issn | 1935-861X |
language | English |
last_indexed | 2024-12-18T00:37:56Z |
publishDate | 2021-09-01 |
publisher | Elsevier |
record_format | Article |
series | Brain Stimulation |
spelling | doaj.art-ece9cc47a11a4ce2a05294e0aa57d6662022-12-21T21:26:57ZengElsevierBrain Stimulation1935-861X2021-09-0114511181125Day-to-day variability in motor threshold during rTMS treatment for depression: Clinical implicationsGonçalo Cotovio0Albino J. Oliveira-Maia1Carter Paul2Francisco Faro Viana3Daniel Rodrigues da Silva4Carolina Seybert5Adam P. Stern6Alvaro Pascual-Leone7Daniel Z. Press8Berenson-Allen Center for Noninvasive Brain Stimulation, Division of Cognitive Neurology, Department of Neurology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, 02215, MA, USA; Champalimaud Research & Clinical Centre, Champalimaud Centre for the Unknown, Lisbon, Portugal; Department of Psychiatry and Mental Health, Centro Hospitalar de Lisboa Ocidental, Lisbon, Portugal; NOVA Medical School, NMS, Universidade Nova de Lisboa, Lisbon, PortugalChampalimaud Research & Clinical Centre, Champalimaud Centre for the Unknown, Lisbon, Portugal; Department of Psychiatry and Mental Health, Centro Hospitalar de Lisboa Ocidental, Lisbon, Portugal; NOVA Medical School, NMS, Universidade Nova de Lisboa, Lisbon, PortugalBerenson-Allen Center for Noninvasive Brain Stimulation, Division of Cognitive Neurology, Department of Neurology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, 02215, MA, USAChampalimaud Research & Clinical Centre, Champalimaud Centre for the Unknown, Lisbon, PortugalChampalimaud Research & Clinical Centre, Champalimaud Centre for the Unknown, Lisbon, PortugalChampalimaud Research & Clinical Centre, Champalimaud Centre for the Unknown, Lisbon, PortugalBerenson-Allen Center for Noninvasive Brain Stimulation, Division of Cognitive Neurology, Department of Neurology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, 02215, MA, USA; Department of Psychiatry, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, 02215, MA, USADepartment of Neurology, Harvard Medical School, Boston, MA, USA; Hinda and Arthur Marcus Institute for Aging Research and Deanna and Sidney Wolk Center for Aging Research, Hebrew SeniorLife, Boston, MA, USA; Institut Guttmann de Neurorehabilitación, Universitat Autonoma de Barcelona, Badalona, Barcelona, SpainBerenson-Allen Center for Noninvasive Brain Stimulation, Division of Cognitive Neurology, Department of Neurology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, 02215, MA, USA; Corresponding author. Berenson-Allen Center for Noninvasive Brain Stimulation, Division of Cognitive Neurology, Department of Neurology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, 330 Brookline Ave Kirstein Building KS 158, Boston, MA, 02215, USA.Background: When repetitive transcranial magnetic stimulation (rTMS) is used to treat medication refractory depression, the treatment pulse intensity is individualized according to motor threshold (MT). This measure is often acquired only on the first day of treatment, as per the protocol currently approved by Food and Drug Administration. Objective: Here, we aimed to assess daily MT variability across an rTMS treatment course and simulate the effects of different schedules of MT assessment on treatment intensity. Methods: We conducted a naturalistic retrospective study with 374 patients from a therapeutic rTMS program for depression that measures MT daily. Results: For each patient, in almost half the TMS sessions, MT varied on average more than 5% as compared to the baseline MT acquired in the first treatment day. Such variability was only minimally impacted by having different TMS technicians acquiring MT in different days. In a smaller cohort of healthy individuals, we confirmed that the motor hotspot localization method, a critical step for accurate MT assessment, was stable in different days, arguing that daily MT variability reflects physiological variability, rather than an artifact of measurement error. Finally, in simulations of the effect of one-time MT measurement, we found that half of sessions would have been 5% or more above or below target intensity, with almost 5% of sessions 25% above target intensity. The simulated effects of weekly MT measurements were significantly improved. Conclusions: In conclusion, MT varies significantly across days, not fully dependent on methods of MT acquisition. This finding may have important implications for therapeutic rTMS practice regarding safety and suggests that regular MT assessments, daily or at least weekly, would ameliorate the effect.http://www.sciencedirect.com/science/article/pii/S1935861X21001509Transcranial magnetic stimulationResting motor thresholdVariabilityDepression |
spellingShingle | Gonçalo Cotovio Albino J. Oliveira-Maia Carter Paul Francisco Faro Viana Daniel Rodrigues da Silva Carolina Seybert Adam P. Stern Alvaro Pascual-Leone Daniel Z. Press Day-to-day variability in motor threshold during rTMS treatment for depression: Clinical implications Brain Stimulation Transcranial magnetic stimulation Resting motor threshold Variability Depression |
title | Day-to-day variability in motor threshold during rTMS treatment for depression: Clinical implications |
title_full | Day-to-day variability in motor threshold during rTMS treatment for depression: Clinical implications |
title_fullStr | Day-to-day variability in motor threshold during rTMS treatment for depression: Clinical implications |
title_full_unstemmed | Day-to-day variability in motor threshold during rTMS treatment for depression: Clinical implications |
title_short | Day-to-day variability in motor threshold during rTMS treatment for depression: Clinical implications |
title_sort | day to day variability in motor threshold during rtms treatment for depression clinical implications |
topic | Transcranial magnetic stimulation Resting motor threshold Variability Depression |
url | http://www.sciencedirect.com/science/article/pii/S1935861X21001509 |
work_keys_str_mv | AT goncalocotovio daytodayvariabilityinmotorthresholdduringrtmstreatmentfordepressionclinicalimplications AT albinojoliveiramaia daytodayvariabilityinmotorthresholdduringrtmstreatmentfordepressionclinicalimplications AT carterpaul daytodayvariabilityinmotorthresholdduringrtmstreatmentfordepressionclinicalimplications AT franciscofaroviana daytodayvariabilityinmotorthresholdduringrtmstreatmentfordepressionclinicalimplications AT danielrodriguesdasilva daytodayvariabilityinmotorthresholdduringrtmstreatmentfordepressionclinicalimplications AT carolinaseybert daytodayvariabilityinmotorthresholdduringrtmstreatmentfordepressionclinicalimplications AT adampstern daytodayvariabilityinmotorthresholdduringrtmstreatmentfordepressionclinicalimplications AT alvaropascualleone daytodayvariabilityinmotorthresholdduringrtmstreatmentfordepressionclinicalimplications AT danielzpress daytodayvariabilityinmotorthresholdduringrtmstreatmentfordepressionclinicalimplications |